0
2022
Stroke Management Market

Stroke Management Market

by Type (Diagnostics and Therapeutics) and Application (Ischemic Stroke and Hemorrhagic Stroke): Global Opportunity Analysis and Industry Forecast, 2021-2030

✷  Report Code: A00539
Pages: 200
Feb 2022 | 26356 Views
Author(s) : Sushant T, Avinash G , Onkar S
Tables: 115
Charts: 51
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Stroke Management Market

Request Now !

Stroke Management Market Statistics 2030:

The global stroke management market size was valued at $31,702.20 million in 2020, and is projected to reach $67,771.95 million by 2030, registering a CAGR of 7.8% from 2021 to 2030. A stroke occurs when a blood vessel in the brain ruptures and bleeds, or when there is a blockage in the blood supply to the brain. The rupture or blockage prevents blood and oxygen from reaching the brain’s tissues. Three types of strokes are prevalent across the globe, which include transient ischemic attack, ischemic stroke, and hemorrhagic stroke. The diagnosis of the stroke includes blood test, computerized tomography scan, magnetic resonance imaging, ultrasound, cerebral angiogram, and echocardiogram. The treatment for the stroke includes aspirin, other antiplatelets, and anticoagulants.  

The growth of the stroke management market is driven by increase in healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population. Moreover, technological advancements for the diagnosis & treatment of stroke contribute toward the growth of the market. However, high cost of diagnosis & treatment and lack of reimbursement policies are expected to hinder the market growth. Conversely, ongoing R&D activities in the field of stroke management are expected to offer lucrative opportunities for the growth of the market.

Stroke-Management-Market

Impact Of Covid-19 On Stroke Management Market (Pre And Post Analysis)

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. Amidst the initial outbreak of COVID-19, reduced hospitals admissions of stroke patients were observed. It was due to the reason that people feared about the infection during a period of distancing and lockdown. Various regions reported the reduction in acute stroke admission in the hospital indicating that many patients with moderate and severe stroke were also avoiding the hospital presentation. For instance, according to the data of the National Institute of Health, in the central and south Texas, the patient admission, treatment, and discharge volumes for acute stroke treatment have decreased significantly since COVID-19–related lockdown orders were issued.

The demand for diagnostic devices of stroke and monitoring devices was reduced. Production plants of devices were shut down during the lockdown imposed in the world. This lockdown created the financial crisis among market players. This further led to disturbances in import and export of the devices across the countries. Overall, the impact of COVID-19 on the stroke management market was recorded to be fairly negative. This was attributed to decrease in demand for diagnostic devices of the stroke disease. Moreover, market players have reduced investment in raw materials and resources, owing to decrease in number of hospital admission of stroke patients.

The global stroke management market is segmented on the basis of type, application, and region. Based on type, the market is segmented into diagnostics and therapeutics. The diagnostics segment is classified into computed tomography scan (CT scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. The therapeutics segment is further classified as tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive. On the basis of application, it is categorized into ischemic stroke and hemorrhagic stroke. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Stroke Management Market
By Type

Your browser does not support the canvas element.

Diagnostics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Type Segment Review

By type, the global stroke management market is classified into diagnostics and therapeutics. Diagnostics segment was the major contributor to the global market in 2020, and is anticipated to remain dominant during the forecast period due to technological advancements in the stroke management devices, increase in adoption of stroke management devices, rise in incidence rate of chronic diseases like diabetes, and increase in number of advanced & effective product launches.

Stroke Management Market
By Application

Your browser does not support the canvas element.

Ischemic Stroke segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Application Segment Review

On the basis of application, the global stroke management market is classified into ischemic stroke and hemorrhagic stroke. Ischemic stroke segment was the major contributor to the global market in 2020, and is anticipated to remain dominant during the forecast period, due to the increase in healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population.

Stroke Management Market
By Region

2030
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific would exhibit the highest CAGR of 9.1% during 2020-2030.

Get more information on this report : Request Sample Pages

Region Segment Review

North America accounted for major share of the global stroke management market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of chronic diseases such as diabetes, surge in demand for stroke management devices, availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities along with large presence of key players, and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period.

Moreover, Japan and China are expected to grow at high CAGR in Asia-Pacific stroke management market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of stroke management.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current stroke management market trends and forecast estimations from 2021 to 2030, which assists to identify the prevailing market opportunities. 
  • An in-depth stroke management market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global the stroke management market is provided.
  • The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2030, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the stroke management market.

Stroke Management Market Report Highlights

Aspects Details
BY TYPE
  • Diagnostics
    • Magnetic Resonance Imaging
    • Carotid Ultrasound
    • Cerebral Angiography
    • Electrocardiography
    • Echocardiography
    • Others
  • Therapeutics
    • Tissue Plasminogen Activator
    • Anticoagulant
    • Antiplatelet
    • Antihypertensive
BY APPLICATION
  • Ischemic Stroke
  • Hemorrhagic Stroke
BY REGION
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Cardinal Health Inc., General Electric Company, Glaxosmithkline Plc, Medtronic Plc, Merck And Co. Inc., Siemens AG
 

Loading Table Of Content...


 
 

The stroke management is expected to rise due to the increase in geriatric population. Numerous technological advancements have been witnessed for the treatment and detection of stroke. North America is projected to be the highest revenue contributor, whereas Asia-Pacific is expected to offer lucrative opportunities to the key players in this market.

Rise in incidence of diabetes, lifestyle changes, technological advancements, increase in patient awareness, and presence of high unmet medical needs in the developing regions drive the growth of this market.

However, high treatment cost and lack of skilled professionals hamper this growth. Majority of the manufacturers and distributors in this market focus on expanding their presence in the emerging economies. North America is expected to dominate the global stroke management market during the forecast period, followed by Europe.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Stroke Management market is $67,771.95 million in 2030.

A. Top companies such as Cardinal Health, Inc., General Electric Company, Siemens AG, MERCK & CO., INC., GLAXOSMITHKLINE PLC, BRISTOL-MYERS SQUIBB COMPANY held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Diagnostics segment is the most influencing segment owing technological advancements in the stroke management devices, increase in adoption of stroke management devices.

A. The forecast period for Stroke Management market is 2020 to 2030

A. The market value of Stroke Management market in 2020 is $31,702.20 million.

A. The base year is 2020 in Stroke Management market

A. The increase in healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population are the key trends in the Stroke Management market report.

A. Asia-Pacific has the highest growth rate of 9.1% in the market which is growing due to presence of large patient population, strong presence of key players, increase in number of hospitals equipped with advanced Stroke Management devices.

A. Yes, the Stroke Management market companies are profiled in the report.

A. Yes, the Stroke Management market report provides PORTER Analysis

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Stroke Management Market

Start reading instantly.
This Report and over 19,659+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Library
    Membership

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers